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Transient systemic inﬂammation has been shown to cause altered behavior both in humans
and in laboratory animals through activation of microglia and heightened level of cytokines
detected in the brain and in the body. Furthermore, both activated microglia and the
increased cytokines level have been associated with the sudden clinical deterioration in
demented people or in aged patients upon systemic inﬂammation.Whilst it is increasingly
becoming clear the role of transient systemic inﬂammation in promoting dementia in aged
individuals, it is still a matter of debate whether prolonged systemic inﬂammation might
persistently modify the brain. In this study, we examined the inﬂuence of a systemic long
term inﬂammatory event on synaptic plasticity. We report that while a short exposure
to LPS produces transient deﬁcit in long term potentiation (LTP) expression, systemic
prolonged inﬂammation impairs LTP in slices of animals previously primed by a Complete
Freund’s adjuvant injection. Interestingly, steroids are able tomodulate this effect: whereas
glucocorticosteroid (GR) activation further reduces LTP, mineralocorticosteroid receptors
(MR) activation promotes the full recovery of LTP. We believe that this research advances
the current understandings on the role of the immune system in the onset and progression
of cognitive deﬁcits following long lasting systemic inﬂammation, and proposes possible
insights on future strategies in order to prevent early dementia in these predisposed
individuals.
Keywords: inflammation, hippocampus, synaptic plasticity, LTP, corticosterone, mineralocorticosteroid receptors,
glucocorticosteroid receptors, LPS
INTRODUCTION
In health and disease, the immune system and the brain constantly
communicate with each other. Speciﬁcally, in quiescent periods,
the immune system positively regulates learning, memory, neural
plasticity, and neurogenesis (Dantzer et al., 2008; Bitzer-Quintero
and Gonzalez-Burgos, 2012; Kohman and Rhodes, 2013). In par-
ticular, during learning or high frequency stimulation, known
to induce Long Term Potentiation (LTP), a cellular correlate of
learning and memory (Maggio and Segal, 2010; Segal et al., 2010),
microglia secretes several mediators which are thought to support
plasticity (Bitzer-Quintero and Gonzalez-Burgos, 2012). Upon
stimulation by endogenous (e.g., injury, stroke, autoimmune
processes) or exogenous challenges (e.g., pathogens or severe psy-
chological stressors), the immune system modiﬁes the delicate
neuro-glial interactive balance and impairs neuronal plasticity and
memory (Besedovsky and del Rey, 2011). To date, however, it is
still under investigation whether the activation of the immune
system upon infection may cause permanent changes in neuronal
functions (Semmler et al., 2007). In a young and healthy brain,
acute confusional state is generally the ﬁrst neurological man-
ifestation due to systemic inﬂammation (Young, 1995). This is
usually a transient condition, accompanied by changes in the EEG
patterns together with an increase in pro-inﬂammatory cytokines
and cortisol levels in the blood stream of patients (Isik and
Caliskan, 2008; van den Boogaard et al., 2010). In old individuals,
acute cognitive impairment commonly occurs in association with
peripheral infection (Wofford et al., 1996; Chiovenda et al., 2002).
In addition, in old persons an increased blood level of systemic
inﬂammation markers is associated with the development of cog-
nitive deﬁcits (Trollor et al., 2012) and greater brain atrophy than
expected for age (Jefferson et al., 2007). Similarly, in healthy aged
mice, i.p. administration of lipopolysaccharide (LPS, mimick-
ing bacterial endotoxin) results both in depression-like behaviors,
deﬁcits in hippocampal-dependent learning and memory (God-
bout et al., 2008) as well as in exaggerated inﬂammatory cytokine
response (Chen et al., 2008). This is thought to be due to “primed”
microglia which may release excessive concentrations of inﬂam-
matory cytokines in the CNS upon receiving a triggering stimulus
(i.d. LPS or peripheral infection; Dilger and Johnson, 2008).
Finally, in chronic neurodegenerative diseases, systemic inﬂam-
mation has been hypothesized to be involved in the pathogenesis
of dementia (Sundelof et al., 2009) and thought to accelerate neu-
rodegeneration and promote delirium (Cunningham et al., 2005;
Murray et al., 2011). Altogether, while it is accepted that systemic
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inﬂammation underlies acute brain dysfunctions and neurological
exacerbations in predisposed subjects, not much is known about
the long term consequences of a persistent systemic inﬂammation.
Among others, systemic inﬂammation is known to activate the
stress response and release of cortisol (corticosterone in rodents;
Wiersinga, 2011). Furthermore, steroids are considered a mile-
stone for the treatment of patients undergoing severe, prolonged
inﬂammation (Patel and Balk, 2012; Sherwin et al., 2012). We
and others have shown that corticosterone may either facili-
tate or depress synaptic plasticity and LTP based on the speciﬁc
activation of its receptors subtypes, the mineralocorticosteroid
receptors (MR) or the glucocorticosteroid receptors (GR), respec-
tively (Alfarez et al., 2006; Joels and Krugers, 2007; Maggio and
Segal, 2010; Krugers et al., 2011; Maggio and Segal, 2012c; Tim-
mermans et al., 2013). While the association between systemic
inﬂammation and steroids is clear, the consequences on synaptic
plasticity upon activation of different steroids receptors in animals
with systemic inﬂammation are yet unknown.
In this study, we tested the effects of short and long term sys-
temic LPS treatment on LTP and its modulation by corticosteroid
receptors. We believe that our ﬁndings add novel insights on the
relationship between inﬂammation and synaptic plasticity and
may help designing future therapeutic strategies to prevent the
long term consequences of systemic inﬂammation.
MATERIALS AND METHODS
MICE AND TREATMENTS
Animal handling was approved by the Institutional Animal Care
and Use Committee, which adheres to the national law, and NIH
rules. Two-months old Balb/cmice underwent two treatment pro-
tocols: in one protocol, mice were exposed to i.p. injections of LPS
(1 mg/Kg) twice a week for a week (short treatment). In the other
one, animals received LPS injections for a month (twice a week;
long treatment). In order to address whether the activation of the
immune system prior to the LPS administration would affect LTP
in a particular manner, we exposed some of the animals to a single
Complete Freund’s Adjuvant (Adj) injection (diluted 1:1 in saline,
100 μL total volume injected/mouse) 24 h prior to the beginning
of the LPS treatment. In total, we had four groups of animals
(n = 8 animals/group at each time point, two slices/animal for
each pharmacological treatment) undergoing either a short or a
long treatment: one group was treated with LPS, and additional
one received Adj, another group was injected with Adj + LPS,
and ﬁnally the control untreated animals. The effects of stress
hormones were studied by applying either Corticosterone (Cort,
100 nM), RU (500 nM) + Cort (MR activation) or Spironolac-
tone (500nM)+Cort (GR activation) directly on the hippocampal
slices, as previously described (Maggio and Segal, 2010). Applica-
tion of MR or GR antagonists alone did not result in any effect
compared to control untreated slices of the respective treatment
group.
ELECTROPHYSIOLOGY IN BRAIN SLICES
Extracellular recordings in hippocampal slices were performed
as previously reported (Maggio and Segal, 2007b, 2011). Brieﬂy,
following anesthesia with ketamine/xylazine (dosage of 100 and
10 mg/Kg, respectively), animals were rapidly decapitated, the
brain removed, and 400 μm slices prepared using a vibroslicer.
Slices were incubated for 1.5 h in a humidiﬁed, carbogenated
(5% CO2 and 95% O2) gas atmosphere at 33 ± 1◦C and per-
fused with ACSF [containing (in micromolar) 124 NaCl, 2 KCl,
26 NaHCO3, 1.24 KH2PO4, 2.5 CaCl2, 2 MgSO4, and 10 glucose,
pH 7.4] in a standard interface chamber. Recordings were made
with a glass pipette containing 0.75 M NaCl (4 M) placed in
the stratum radiatum CA1. Stimulation was evoked using a pulse
stimulator and delivered through a bipolar nichrome electrode.
LTP was induced by high-frequency stimulation (HFS) consisting
of 100 pulses at twice the test intensity, delivered at a frequency of
100Hz (100Hz, 1 s). Before applying the tetanic stimulation, base-
line values were recorded at a frequency of 0.033 Hz. Responses
were digitized at 5 kHz and stored on a computer. Off-line anal-
ysis and data acquisition was performed by Spike 2 software. All
numerical data are expressed as mean ± SEM, and EPSP slope
changes after tetanic stimulation were calculated with respect to
baseline. There were no systematic differences in the magnitudes
of the baseline responses in the different conditions. Unless other-
wise indicated, statistical evaluations were performed by applying
either one way or twowaysANOVA as the casemay be, followed by
a post hoc Tukey’s test, p values of 0.05were considered a signiﬁcant
difference between means.
RESULTS
PROLONGED SYSTEMIC INFLAMMATION PERSISTENTLY MODIFIES
SYNAPTIC PLASTICITY IN THE HIPPOCAMPUS
It is unclear whether exposure to a long lasting systemic inﬂam-
mation may produce enduring changes in the brain. Here, we
investigated the effects that two treatments with LPS (1 mg/Kg)
of different duration might produce on LTP at the CA3-CA1 hip-
pocampal synapses. In one treatment protocol, mice were exposed
to i.p. injections of LPS twice a week for a week (short treatment),
in the other one, animals received LPS injections for a month
(twice a week; long treatment). To address whether the activa-
tion of the immune system prior to the LPS administration would
have affected LTP in any manner, we exposed some of the ani-
mals to a single Adj injection 24 h prior to the beginning of the
LPS treatment. In total, we had four groups of animals enrolled
in the study: one that was treated with LPS, one that received
Adj, another group received Adj + LPS, and ﬁnally the control
untreated animals. A short treatment with LPS reduced LTP both
in LPS and in Adj + LPS mice (1.49 ± 0.04 and 1.36 ± 0.04,
respectively; values at 85 min of recordings) compared to Adj and
control groups (1.67 ± 0.05 and 1.77 ± 0.04, respectively; val-
ues at 85 min of recordings; F = 10.71, p < 0.001, Figure 1A).
Interestingly, LTP fully recovered in LPS and Adj + LPS animals
1 week upon interruption of LPS injections. Indeed, LTP in these
animals reached similar values to those of the other groups. These
data show that a short duration treatment with LPS affects LTP
transiently: LTP is restored in a time frame of a week after the
interruption of the LPS administration. However, a different phe-
nomenon occurs if the treatment is being prolonged for a month.
Indeed, LTP was impaired in Adj + LPS (1.33 ± 0.04) animals fol-
lowing a 1 month exposure to LPS compared to the other groups
(1.76 ± 0.05, 1.74 ± 0.04, and 1.73 ± 0.05 for LPS, Adj, and con-
trol, respectively; F = 71.38, p < 0.001; Figure 1C). Nevertheless,
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FIGURE 1 | LTP in hippocampal slices of animals undergoing LPS
treatments of different duration. LTP is impaired in animals treated with
LPS and LPS + Adj for a week (A). Upon interruption of the treatment for a
week LTP is restored in LPS and LPS + Adj animals (B). LTP is persistently
impaired in animals treated with LPS + Adj for a month (C) even after
interruption of treatment (D) 1 week upon treatment interruption,
(E) 1 month following treatment interruption, (F) 2 months following
treatment interruption. (G) A combined analysis of all the data presented,
conducted at 85 min after the tetanic stimulation. Further details of the
results and the statistical comparisons are described in the Section
“Results.” Statistical analyses were made with two way analysis of
variance, followed by post hoc Tukey’s comparisons. In each panel of data,
the arrow indicates the time of HFS delivery, the top traces are sample
illustrations of original records before (a) and after (b) tetanic stimulation.
***p < 0.001.
it is interesting to note that animals that underwent LPS treatment
for a month did not develop any signiﬁcant deﬁcit in LTP com-
pared to control (Figure 1C). This result is indeed puzzling and
it requires additional experiments to identify the possible causes
of this effect. Remarkably, halting LPS treatment after a month
did not restore LTP back to normal levels. Adj + LPS animals
demonstrated deﬁcits in expressing a full LTP following tetanic
stimulation even at 1 week (Figure 1D), 1 month (Figure 1E), and
2months (Figure 1F) after the LPS treatment has been stopped. In
order to quantify the effects of duration of LPS treatment (factor
a) and the different groups of animals exposed to them (factor b)
we run a two-ways ANOVA (Figure 1G) which revealed an overall
signiﬁcant statistical difference for factor a (F = 23.24; p < 0.01)
and for factor b (F = 65.22; p < 0.01) as well as a signiﬁcant inter-
action between the two (F = 15.95; p < 0.01). In summary, these
experiments show that a short exposure to LPS produces transient
deﬁcit in LTP expression in animals that were previously treated
with Adj and in those that have received LPS only. LTP is restored
back to normal levels if LPS exposure lasts for a week. A prolonged
treatment with LPS in animals previously exposed to Adj induces
persistent reduction in LTP that could not be re-established to
normal levels even 2 months after the termination of the LPS
treatment.
CORTICOSTERONE REDUCES LTP IN SLICES OF ANIMALS UNDERGOING
PROLONGED SYSTEMIC INFLAMMATION
Steroids have been considered a therapeutic option for patients
undergoing severe, protracted inﬂammation (Patel andBalk, 2012;
Sherwin et al., 2012). Moreover, even though activation of the
stress response and release of steroids are known outcomes of
prolonged inﬂammation (Wiersinga, 2011), no information is
currently available on the effects of corticosterone (CORT) on
synaptic plasticity in this setting. In order to tackle this issue, we
investigated the consequences of CORT application on LTP in hip-
pocampal slices of animals undergoing LPS treatment of different
duration. Application of 100 nM CORT reduced LTP in control
untreated animals (1.34 ± 0.04 compared to 1.77 ± 0.04 in slices
from control animals not exposed to CORT, p < 0.001, Figure 5),
an effect already reported by us (Maggio and Segal, 2007a) and
other groups (Joels et al., 2008; Wiegert et al., 2008). Interestingly,
however, application of CORT to slices of animals exposed to a
short treatment with LPS resulted in even weaker LTP in LPS and
Adj + LPS mice (1.10 ± 0.04 and 1.14 ± 0.04, respectively) com-
pared to Adj and control groups (1.38 ± 0.05 and 1.34 ± 0.04,
respectively; F = 74.21, p < 0.01; Figure 2A). Likewise, CORT
exposure resulted in a LTP of lower magnitude compared to the
one evoked in slices from LPS and Adj + LPS animals not exposed
to CORT (Figure 5). These effects of CORT completely recov-
ered 1 week upon interruption of LPS injections (Figure 2B). In
contrast, however, CORT exposure of slices from animals treated
with LPS for 1 month resulted in a persistent reduction of LTP.
LTP was impaired in Adj + LPS animals (1.16 ± 0.05) follow-
ing a 1 month exposure to LPS compared to the other groups
(1.40± 0.08, 1.39± 0.03, and 1.38± 0.04 for LPS,Adj, and control
respectively; F = 16.08, p < 0.001; Figure 2C). Remarkably, CORT
still reduced LTP at 1 week (Figure 2D), 1 month (Figure 2E), and
2 months (Figure 2F) after the LPS treatment has been halted. In
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FIGURE 2 | CORT depresses LTP in hippocampal slices of animals
undergoing LPS treatment of different duration. LTP is highly impaired
upon CORT exposures in slices from animals treated with LPS and
LPS + Adj for a week (A). Upon interruption of the treatment for a week
LTP is restored at the control levels (B). A persistent decrease in LTP is
observed in slices from animals treated with LPS + Adj for a month
(C) even after interruption of treatment (D) 1 week upon treatment
interruption, (E) 1 month following treatment interruption, (F) 2 months
following treatment interruption. (G) A combined analysis of all the data
presented, conducted at 85 min after the tetanic stimulation. Further
details of the results and the statistical comparisons are described in the
Section “Results.” Statistical analyses were made with two way analysis of
variance, followed by post hoc Tukey’s comparisons. In each panel of data,
the arrow indicates the time of HFS delivery, the top traces are sample
illustrations of original records before (a) and after (b) tetanic stimulation.
***p < 0.001.
order to quantify the effects of CORT in groups of animals (factor
b) which underwent to LPS treatments of different duration (fac-
tor a), we run a two-ways ANOVA (Figure 2G) test which revealed
an overall signiﬁcant statistical difference for factor a (F = 12.26;
p< 0.01) and factor b (F = 92.86; p< 0.001) as well as a signiﬁcant
interaction between the two (F = 8.66; p < 0.01). In summary,
these experiments show that (1) CORT further decreases LTP in
animals undergoing a short or long exposure to LPS; (2) CORT
effects on LTP are long lasting following a long LPS treatment; (3)
CORT potentiates the effects of the systemic Adj + LPS injections
on LTP reduction.
MR ACTIVATION ENHANCES LTP IN SLICES OF ANIMALS UNDERGOING
PROLONGED SYSTEMIC INFLAMMATION
CORT is known to modulate LTP through two different types of
receptors: theMRand theGR. In order to study the contributionof
each receptor to the effects of CORTonLTP,a speciﬁc combination
of MR/GR antagonists in presence of CORT was applied to the
slices from different groups of animals undergoing short and long
LPS treatment. Bath application of RU38486 (RU, 500 nM), a
blocker of GR, and CORT (100 nM) has been shown to reliably
activate MR (Maggio and Segal, 2007a).
Indeed,MR activation strikingly potentiated LTP in slices from
Adj + LPS animals compared to the other groups. Following
1 week of LPS treatment, MR activation resulted in a short lasting
LTPenhancementboth inuntreated animals aswell as inAdj+LPS
mice, notably with a stronger effect in the latter group (p < 0.0001;
Figures 3A and 5). Surprisingly, an LTP of greater magnitude was
induced in slices of 1 month Adj + LPS mice upon MR stim-
ulation. The delivery of a tetanus following application of RU
and CORT resulted in a potentiation of 2.69 ± 0.09 in spite of
2.011 ± 0.05, 2.04 ± 0.04, and 2 ± 0.03 of LPS, Adj, and control,
respectively (F = 153.91, p < 0.001; Figure 3C). This effect per-
sisted at 1 week (Figure 3D), 1 month (Figure 3E), and 2 months
(Figure 3F) upon halting LPS treatment. In order to quantify the
effects of MR activation in slices of animals (factor b) undergoing
to LPS treatments of different duration (factor a), we run a two-
way ANOVA (Figure 3G). This test revealed an overall signiﬁcant
statistical difference for factor a (F = 31.62; p < 0.001) and for
factor b (F = 586.12; p < 0.001) as well as a signiﬁcant interaction
between the two (F = 31.16; p < 0.001).
In brief, these experiments show that (1) MR activation
enhances LTP in animals undergoing a short or long exposure
to LPS; (2) MR effects on LTP are long lasting following a pro-
tracted LPS treatment; (3)MR activation reverses the reduction in
LTP induced by systemic Adj + LPS injections.
GR ACTIVATION INDUCES DEPRESSION OF SYNAPTIC TRANSMISSION
IN SLICES FROM ANIMALS FOLLOWING PROLONGED SYSTEMIC
INFLAMMATION
Bath application of Spironolactone (Spiro, 500 nM), an MR
blocker, together with CORT (100 nM) activates GR (Avital et al.,
2006; Maggio and Segal, 2007a). Stimulation of GR activation
reduced LTP in slices of untreated animals, however a greater effect
occurred inAdj+ LPS treatedmice (Figures 4A and 5). Unexpect-
edly, GR were able to convert LTP in a slow onset depotentiation
in slices of 1 month Adj + LPS treated mice: a tetanic stimulation
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FIGURE 3 | MR activation enhances LTP in hippocampal slices of
animals undergoing LPS treatment of different duration. LTP is highly
enhanced upon MR activation in slices from animals treated with LPS and
LPS + Adj for a week (A). Upon interruption of the treatment for a week
LTP is restored at the control levels (B). A persistent increase in LTP is
observed in slices from animals treated with LPS + Adj for a month
(C) even after interruption of treatment (D) 1 week upon treatment
interruption, (E) 1 month following treatment interruption, (F) 2 months
following treatment interruption. (G) A combined analysis of all the data
presented, conducted at 100 min of recording. Further details of the results
and the statistical comparisons are described in the Section “Results.”
Statistical analyses were made with two way analysis of variance, followed
by post hoc Tukey’s comparisons. In each panel of data, the arrow indicates
the time of HFS delivery, the top traces are sample illustrations of original
records before (a) and after (b) tetanic stimulation. ***p < 0.001.
delivered after washing in Spiro and CORT resulted in a reduced
level of transmission in these animals (0.84 ± 0.04) compared to
the other groups (1.26± 0.03, 1.25± 0.04, and 1.25± 0.04 of LPS,
Adj, and control, respectively; F = 124.42, p < 0.001; Figure 4C).
A similar effect was reproduced at 1 week (Figure 4D), 1 month
(Figure 4E), and 2 months (Figure 4F) after discontinuation of
FIGURE 4 | GR activation converts LTP in slow onset depotentiation in
hippocampal slices of Adj + LPS animals treated for a longer time
period. LTP is highly impaired upon GR activation in slices from animals
treated with LPS and LPS + Adj for a week (A). Upon interruption of the
treatment for a week LTP is restored at the control levels (B). A conversion
from LTP to slow onset depotentiation is observed in slices from animals
treated with LPS + Adj for a month (C) even after interruption of treatment
(D) 1 week upon treatment interruption, (E) 1 month following treatment
interruption, (F) 2 months following treatment interruption. (G) A combined
analysis of all the data presented, conducted at 100 min of recording.
Further details of the results and the statistical comparisons are described
in the Section “Results.” Statistical analyses were made with two way
analysis of variance, followed by post hoc Tukey’s comparisons. In each
panel of data, the arrow indicates the time of HFS delivery, the top traces
are sample illustrations of original records before (a) and after (b) tetanic
stimulation. ***p < 0.001.
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FIGURE 5 | Different animals groups express magnitude of LTPs upon
different steroid receptor stimulation at different time points. A
combined analysis of all the data presented. Further details of the results
and the statistical comparisons are described in the Section “Results.”
Statistical analyses were made with two way analysis of variance, followed
by post hoc Tukey’s comparisons. ***p < 0.001.
LPS injections. A two-ways ANOVA quantifying the effects of GR
activation in groups of animals (factor b) undergoing to LPS treat-
ment of different duration (factor a; Figure 4G) detected an overall
signiﬁcant statistical difference for factor a (F = 7.98; p < 0.0001)
and for factor b (F = 348.05; p < 0.001) as well as a signiﬁcant
interaction between the two (F = 29.97; p < 0.001). Summariz-
ing, these experiments show that (1) GR activation reduces LTP in
animals following a short exposure to LPS and (2) converts LTP in
a slow onset depotentiation in animals treated for a longer period.
DISCUSSION
In this study, we report the effects of peripheral inﬂammation on
LTP and its modulation by steroids hormones. A major ﬁnding of
ourwork is the evidence that systemic inﬂammation leads todiffer-
ent outcomes on LTP depending on its duration. Speciﬁcally, short
lasting inﬂammation transiently weakens LTP while, in contrast,
the exposure to LPS for amonth disrupts LTP for a longer period in
slices of animals that have previously received Adj. This effect per-
sists even upon discontinuation of the LPS treatment. Although
we have not addressed the possible mechanisms in charge of this
phenomenon, based on current literature (Dilger and Johnson,
2008; Norden and Godbout, 2013) a possible explanation may
consider the dual role of Adj both in “priming” the immune sys-
tem (Staykova et al., 2008) as well as in promoting long lasting BBB
breakdown (Rabchevsky et al., 1999). In this setting, following
Adj treatment, a prolonged peripheral inﬂammation may release
excessive concentrations of inﬂammatory cytokines, such as IL-
1, IL-6, TNF-α, PGE2 in the CNS (Lynch et al., 2004; Dilger and
Johnson, 2008) which may ultimately cause LTP impairment in
these animals. In this respect, it is important to consider the long
time frame of the systemic inﬂammation which indicates this phe-
nomenon to be a chronic condition rather than an acute reaction
to a noxious stimulus. It is therefore tempting to think that some-
how a long lasting systemic inﬂammationmay persistently modify
brain functioning even after its remittance. Currently, however,
there are no studies that have focused on such hypothesis. Needless
to say, understanding the biological causes of this phenomenon
seems of paramount importance to improve long term care of
patients experiencing those conditions in order to prevent early
onset of dementia (Barichello et al., 2005; Comim et al., 2009).
Another major ﬁnding of our study is the modulation of LTP
by steroid hormones in animals undergoing LPS treatment. The
effects of steroids seem to depend on the duration of the periph-
eral inﬂammation, with longer lasting effects in slices of animals
undergoing a prolonged LPS treatment. This evidence shows that
even if enduring inﬂammation has triggered persistent changes
in the brain, a modiﬁcation of such mechanisms is still possible,
hence opening a window of opportunity for future intervention.
Furthermore, the demonstration that steroids application in the
slice is able to alter the outcomes of persistent inﬂammation shows
that LPS-induced changes occur in the brain itself and are not an
epiphenomenon of a condition taking place in the rest of the body.
Previous studies have suggested that CORT inﬂuences LTP in
diverse manners according to the type of receptor (GR or MR)
that has been activated (Joels and Krugers, 2007; Maggio and
Segal, 2012b). In our experiments CORT reduced LTP in slices
of Adj + LPS animals as well as in control untreated animals.
This result is possibly due to a summation of the MR and GR
activation in the slices, likely with a predominant GR effect. In
fact, this present data as well as our previously published obser-
vations (Maggio and Segal, 2007a, 2009, 2012a,c) have shown
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that single activation of MR and GR, respectively either facil-
itated LTP or decreased it leading to a depotentiation of the
network. Normally, the application of CORT in the slice results
in the simultaneous stimulation of both receptors, however as
intracellular MR are almost saturated at the baseline conditions
(Maggio and Segal, 2012b), CORT likely causes an unbalanced
response towards GR. Despite the mechanisms involved, it is
interesting to look at our data in a clinical perspective. Steroids
treatment has been shown to be beneﬁcial in treating persistent
inﬂammation (Batzoﬁn et al., 2011; Sherwin et al., 2012), how-
ever, taken our ﬁndings in consideration, what would be their
effect on cognition? Would they impair either the possibility to
form new memories or recalling old ones in these patients? Fur-
thermore, in patients recovering fromprolonged sepsis, which role
do steroids have in respect to the patient’s tendency in developing
early cognitive impairment? These are interesting questions which
have not been currently addressed. Indeed, additional behav-
ioral experiments need to be performed in order to clarify these
issues.
Activation of MR has been previously shown to enhance LTP
in the hippocampus (Avital et al., 2006; Maggio and Segal, 2012a).
In the current study, we successfully replicated previous ﬁnd-
ings, however in the context of prolonged systemic inﬂammation
the effects of MR activation were even more striking than the
ones previously reported. MRs are known to enhance LTP in
the hippocampus through the activation of Voltage Gated Ca2+
Channels (VGCCs; Maggio and Segal, 2007a, 2012a). VGCCs
have a higher threshold of activation therefore while on the
one hand they may have a secondary function in inducing
tetanic stimulation-evoked LTP, they may play a pivotal role in
synaptic plasticity in situations where, upon challenging a net-
work, a novel threshold for LTP is being set. MR activation
may promote this change by affecting the inhibitory tone of
the hippocampal network (Maggio and Segal, 2012a,c). Indeed
more puzzling is the further enhancement in LTP following MR
stimulation in slices of animals undergoing persistent inﬂamma-
tion. Two possible hypotheses may be put forward in order to
explain this ﬁnding. In one case, the continuous inﬂammatory
challenge may alter the inhibitory tone on pyramidal cells and
enhance excitability of the slice. Alternatively, persistent inﬂam-
mation may promote a homeostatic change of the network which
through calcium stores (Maggio and Segal, 2007a; Vlachos et al.,
2008, 2009; Segal et al., 2010) might be in charge of the MR
dependent-additional enhancement of LTP.While the former the-
ory does not seem to be likely (baseline responses under MR
activation were not affected), the latter one looks more promis-
ing and additional experiments need to be conducted in order
to better understand the molecular players in charge of this
phenomenon.
It is interesting to consider what might be the role of MR in
learning and memory and whether they would be able to reverse
the cognitive changes induced by the persistent inﬂammation.
Deﬁnitely, additional experiments should evaluate whether MR
activation in the brain might have a preventive outcome in halting
cognitive impairments following systemic inﬂammation.
In summary, our study shows that prolonged inﬂammation dis-
rupts LTP in the hippocampus. A potential strategy aiming at MR
activation in this setting might reverse the effects of inﬂammation
on cognition as well as circumvents the deleterious effects of
steroids on LTP.
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